Hap Trading, LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 11, 2018	SELL	$51.15 - $61.0 $2.61 Million - $3.12 Million	-51,100 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$50.85 - $65.1 $488,160 - $624,960	-9,600 Reduced 15.82%	51,100 $18,000
Q3 2017 Nov 08, 2017	BUY	$48.6 - $60.1 $2.95 Million - $3.65 Million	60,700	60,700 $65,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.